648 related articles for article (PubMed ID: 20203300)
1. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
[TBL] [Abstract][Full Text] [Related]
2. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation.
Wan JB; Huang LL; Rong R; Tan R; Wang J; Kang JX
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2487-94. PubMed ID: 20705919
[TBL] [Abstract][Full Text] [Related]
3. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
4. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
5. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice.
Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1474-8. PubMed ID: 15178562
[TBL] [Abstract][Full Text] [Related]
7. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
8. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
9. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
10. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
[TBL] [Abstract][Full Text] [Related]
11. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development.
Luchtefeld M; Grothusen C; Gagalick A; Jagavelu K; Schuett H; Tietge UJ; Pabst O; Grote K; Drexler H; Förster R; Schieffer B
Circulation; 2010 Oct; 122(16):1621-8. PubMed ID: 20921438
[TBL] [Abstract][Full Text] [Related]
13. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
[TBL] [Abstract][Full Text] [Related]
15. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
16. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice.
George J; Afek A; Abashidze A; Shmilovich H; Deutsch V; Kopolovich J; Miller H; Keren G
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2636-41. PubMed ID: 16195475
[TBL] [Abstract][Full Text] [Related]
17. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
18. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
[TBL] [Abstract][Full Text] [Related]
19. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
20. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
